Biotech Investors & VC Firms in North America
1595 firms in this list, with a median first check of $500K. 348 of them lead rounds. Generated from verified public data and updated continuously.
Innovation Engine
TokyoPre-Seed–Growth
3 people
Stone Bridge Ventures
SeoulSeed–Late Stage
Melnichek Investments
LimassolSeed–Series A
2 people
TD Growth Capital Co. Ltd.
ShanghaiSeed–Late Stage
3 people
Elmirate Capital
DubaiSeed–Late Stage$1M – $250M
Global Startup Acceleration Program (JETRO GSAP)
TokyoPre-Seed–Late Stage
Chemelot Ventures
Seed–Late Stage
2 people
Bird B. AG
SchaffhausenSeed–Growth
1 person
Danen Capital
ShenzhenSeed–Growth
2 people
Levante Capital
BlaricumSeed–Series A$2M
2 people
Strategic Investment Partners Inc.
TokyoSeed–Growth
2 people
Vamare Investments Group
Athens
Next Sequence
2 people
Aligned Health Ventures
Seed
1 person
Beyond Impact
Luxembourg
1 person
Hokkaido Venture Capital, Inc.
SapporoPre-Seed–Growth
1 person
Virtus Inspire Ventures
Seed–Series A
7 people
UCB Ventures
BrusselsSeed–Series A
5 people
TriWise Capital
ShenzhenPre-Seed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
Pinetum Ventures
Pre-Seed–Seed$130K
1 person
Shinhan Venture Investment
SeoulSeries A–Series B
1 person
Start2 Group
München
WERU Investment Co. Ltd.
TokyoSeed–Series A
Related lists
Investors & VC Firms in North America (13389)Investors & VC Firms in United States (12432)Investors & VC Firms in Europe (5844)Investors & VC Firms in Global (4733)AI & Machine Learning Investors & VC Firms (4559)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4221)Healthtech Investors & VC Firms (4191)Enterprise Software Investors & VC Firms (4101)Crypto & Web3 Investors & VC Firms (3971)
Data sourced from public filings and firms' own websites — see our methodology.
















